EDIT
Editas Medicine Inc
NASDAQ: EDIT · HEALTHCARE · BIOTECHNOLOGY
$2.82
-7.84% today
Updated 2026-04-29
Market cap
$284.81M
P/E ratio
—
P/S ratio
7.03x
EPS (TTM)
$-1.80
Dividend yield
—
52W range
$1 – $5
Volume
1.7M
Editas Medicine Inc (EDIT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $1.63M | $6.05M | $13.73M | $31.94M | $20.53M | $90.73M | $25.54M | $19.71M | $78.12M | $32.31M | $40.52M |
| Revenue growth (YoY) | — | — | — | +271.6% | +126.8% | +132.6% | -35.7% | +341.9% | -71.8% | -22.8% | +296.3% | -58.6% | +25.4% |
| Cost of revenue | $1.59M | $5.07M | $18.85M | $56.98M | $83.16M | $90.65M | $96.90M | $158.00M | $5.05M | $6.34M | $6.06M | $5.81M | $5.28M |
| Gross profit | $-1.59M | $-5.07M | $-17.22M | $-50.93M | $-69.43M | $-58.72M | $-76.37M | $90.73M | $25.54M | $19.71M | $72.06M | $32.31M | $40.52M |
| Gross margin | — | — | -1056.9% | -841.3% | -505.8% | -183.9% | -372.0% | 100.0% | 100.0% | 100.0% | 92.2% | 100.0% | 100.0% |
| R&D | $1.59M | $5.07M | $18.85M | $56.98M | $83.16M | $90.65M | $96.90M | $158.00M | $142.51M | $174.96M | $177.65M | $199.25M | $89.95M |
| SG&A | $3.63M | $7.65M | $18.09M | $46.26M | $50.50M | $55.01M | $64.56M | $67.58M | $76.18M | $70.70M | $69.65M | $71.99M | $49.90M |
| Operating income | $-5.22M | $-12.72M | $-35.31M | $-97.19M | $-119.93M | $-113.73M | $-140.92M | $-134.84M | $-193.15M | $-225.95M | $-169.18M | $-251.15M | $-99.34M |
| Operating margin | — | — | -2167.7% | -1605.6% | -873.6% | -356.1% | -686.4% | -148.6% | -756.1% | -1146.3% | -216.6% | -777.2% | -245.2% |
| EBITDA | $-5.22M | $-13.49M | $-72.29M | $-96.07M | $-116.66M | $-110.47M | $-138.09M | $-130.88M | $-188.09M | $-219.61M | $-163.12M | $-233.11M | $-148.61M |
| EBITDA margin | — | — | -4437.4% | -1587.1% | -849.8% | -345.9% | -672.6% | -144.3% | -736.3% | -1114.1% | -208.8% | -721.4% | -366.8% |
| EBIT | $-5.22M | $-13.65M | $-72.76M | $-97.27M | $-119.35M | $-113.73M | $-140.92M | $-134.84M | $-193.15M | $-225.95M | $-169.18M | $-238.92M | $-153.89M |
| Interest expense | — | $34000.00 | $143000.00 | $62000.00 | $978000.00 | $3.44M | $7.31M | $2.60M | $5.70M | $4.22M | — | $2.19M | $6.17M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.35M | $-13.69M | $-72.90M | $-97.18M | $-120.32M | $-109.95M | $-133.75M | $-109.41M | $-185.11M | $-204.35M | $-153.22M | $-237.09M | $-160.06M |
| Net income growth (YoY) | — | -155.8% | -432.7% | -33.3% | -23.8% | +8.6% | -21.6% | +18.2% | -69.2% | -10.4% | +25.0% | -54.7% | +32.5% |
| Profit margin | — | — | -4475.1% | -1605.5% | -876.5% | -344.3% | -651.4% | -120.6% | -724.7% | -1036.7% | -196.1% | -733.7% | -395.0% |